Semaglutide Linked to NAION Risk - Takeaways - MDSpire
From the Journals

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

  • By

  • Andrea Surnit

  • May 11, 2026

  • 3 min

Share

  • 1

    Semaglutide linked to higher NAION risk in diabetes patients.

  • 2

    Retrospective analysis involved 3.35 million patients.

  • 3

    Risk emerged significantly after 2 years.

  • 4

    Patients aged 40-64, females, and those with hypertension showed higher risks.

  • 5

    Study findings are hypothesis-generating due to limitations.

  • 6

    Future studies needed for better evaluation.

  • 7

    No conflicts of interest reported by researchers.

Original Source(s)

Semaglutide Linked to NAION Risk

  • by Andrea Surnit

  • May 11, 2026

Related Content

The Smart Contact Lens Evolves

New research shows how microstructured contact lenses can track eye movements with remarkable accuracy using Moiré patterns

  • May 12, 2026

  • 3 min
CSO Meeting 2026 Highlights Convergence of Innovation and Clinical Practice

More than 300 professionals gathered for three days of innovation, education, and collaboration, highlighting the latest advances in ophthalmic technology and clinical practice

  • May 12, 2026

  • 2 min
The Next Frontier in Wet AMD

AI-driven therapy planning is turning OCT from a monitoring tool into a forecasting engine for retina specialists